Darden Wealth Group’s SeaStar Medical ICU Stock Holding History

Darden Wealth Group’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-382	Closed	-$42.2K	–	110
2023 Q4	$42.2K	Buy	+382	New	+$56.5K	0.04%	101

Other funds holding ICU

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return

MGIA

Moneta Group Investment Advisors St Louis, Missouri $13.5B AUM 24.62% 1-Year Est. Return

SWA

SFMG Wealth Advisors Plano, Texas $1.66B AUM 27.11% 1-Year Est. Return

Darden Wealth Group's ICU Position: Q1 2024 in Review

Darden Wealth Group sold out of SeaStar Medical (ICU) in Q1 2024, closing a stake of 382 shares — an estimated $42.2K sold.

Darden Wealth Group first reported a position in ICU in Q4 2023 and held it in 1 quarter. The position peaked at $42.2K in Q4 2023. 28 funds tracked by Wall St. Rank hold ICU as of Q1 2024.

Darden Wealth Group reported no remaining SeaStar Medical position as of Q1 2024 after selling out during the quarter.
Darden Wealth Group sold 382 SeaStar Medical shares in Q1 2024, an estimated $42.2K.
Darden Wealth Group first reported a position in SeaStar Medical in Q4 2023 and held it in 1 quarter.
Darden Wealth Group's SeaStar Medical position peaked at $42.2K in Q4 2023.
28 funds tracked by Wall St. Rank held SeaStar Medical as of Q1 2024.

Based on Darden Wealth Group's 13F filing for Q1 2024, filed 8 May 2024.